Menu
← Oncology Approval Tracker
FDA DECISION ·
Cyclophosphamide injection (Sandoz)
cyclophosphamide · Sandoz
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
A 100 mg/mL IV solution for labeled adult uses including malignant lymphomas, myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma and breast carcinoma.
LAMPGEN ANALYSIS
Why it matters
The Sandoz solution added a new presentation of a longstanding alkylating treatment for multiple adult malignancies.
What research teams should watch
Verify concentration and excipients before preparation. The label limits pediatric use because of alcohol and propylene glycol content.
PRIMARY RECORDS